Patients living with Haemophilia A in Malta are now starting to receive a new treatment through Mater Dei Hospital.The Health Ministry announced that Emicizumab has begun being provided to people with the rare blood disorder, which is caused by a deficiency of Factor VIII, a protein needed for normal blood clotting.Unlike traditional treatments that require frequent intravenous infusions, Emicizumab is administered through injections under the skin and requires treatment far less often.The first patients have already started receiving the medication, with the service set to expand gradually over the coming months. The long-term aim is to allow eligible patients to self-administer the treatment at home.Deputy Prime Minister and Health Minister Ian Borg said the introduction of Emicizumab forms part of ongoing efforts to improve access to medicines and innovative treatments in Malta and Gozo.Chief Medical Officer Dr Clarence Pace said the treatment will mean fewer hospital visits and fewer difficulties for patients, while offering greater independence and flexibility in their daily lives.The Health Ministry said the measure is expected to improve both clinical outcomes and quality of life for people living with the condition.What do you make of this latest healthcare investment?•